Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
Clinical and Molecular Hepatology
;
: 417-420, 2013.
Artigo
em Inglês
| WPRIM
| ID: wpr-34823
ABSTRACT
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Vasoconstritores
/
Bilirrubina
/
Síndrome Hepatorrenal
/
Lipressina
/
Tomografia Computadorizada por Raios X
/
Evolução Fatal
/
Creatinina
/
Eletrocardiografia
/
Mucosa Intestinal
/
Intestinos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Clinical and Molecular Hepatology
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS